DOCSLIB.ORG

Communicable Disease Updates Communicable Disease 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Volume III Issue III | May 2018 A Monterey County Health Department bi-monthly newsletter summarizing national, state, and local public health-related issues for county providers. In this Issue: Important Contacts: Communicable Disease Updates Communicable Disease 1. Commonly Reported in 2017 Unit 2. Vaccines Phone: (831) 755-4521 3. STD Fax: (831) 754-6682 4. Tuberculosis Health Officer Chronic Disease Updates Phone: (831) 755-4585 1. Prevention First 1305 Update After Hours: (831) 755-5100 2. Diabetes 3. Opioid Safety Tuberculosis Control Unit 4. Heart Health Phone: (831) 755-4593 5. Grant Opportunities Fax: (831) 796-1272 6. Upcoming Conferences 7. Upcoming Webinars Environmental Health 8. Subscriber's Corner Consumer Protection Phone: (831) 755-4540 Communicable Disease Updates Commonly Reported Communicable Diseases in 2017 Vaccines New Shingles Vaccine: What You Need to Know Shingles vaccination is the only way to protect against shingles and postherpetic neuralgia (PHN), the most common complication from shingles. The CDC recommends that healthy adults 50 years and older get two doses of the shingles vaccine called Shingrix®, separated by 2 to 6 months, to prevent shingles and the complications from the disease. Shingrix provides strong protection against shingles and PHN. Two doses of Shingrix is more than 90% effective at preventing shingles and PHN. Protection stays above 85% for at least the first four years after you get vaccinated. Shingrix is the preferred vaccine, over Zostavax®, a shingles vaccine in use since 2006. Shingrix is available in Monterey County. If you do not provide immunizations in your clinic, please refer your patients to the Health Map Vaccine Finder website (https://vaccinefinder.org/) to identify a location near them offering the vaccine. STDs Concerning Increase in Syphilis in Women and in Congenital Syphilis: An Update for Monterey County Health Care Providers Early syphilis (primary, secondary, and early latent) has been increasing in Monterey County since 2010. In 2017, there were 70 cases of newly diagnosed early syphilis reported among Monterey County residents (compared to 1 reported case in 2009). From 2012 to 2014, the annual number of reported early syphilis cases among women in California more than doubled from 248 cases to 594. The annual number of reported congenital syphilis in California cases more than tripled during the same period, from 30 to 100. Three cases of congenital syphilis have been reported in Monterey County since 2015. No congenital syphilis cases had been reported in Monterey County in the 15 years prior to 2015. Recommendations for Providers: Test for syphilis. Syphilis serology testing should include a rapid plasma regain (RPR) with titer that reflexes to a treponemal test if the RPR is reactive. o Pregnant women should be screened for syphilis at their first prenatal care visit. Testing should be repeated during the third trimester and at delivery for women who are at high risk for syphilis. o Sexually active gay, bisexual, and other men who have sex with men should be screened annually or sooner following disclosure of high risk sexual activity. Follow the Centers for Disease Control and Prevention’s (CDC’s) guidelines for treatment. Detailed guidelines are available here. o All providers are encouraged to treat patients and their partners in their practice. Family PACT, Medi-Cal, and private insurances normally cover testing and treatment for syphilis. o Call the Health Department’s Communicable Disease Unit (831-755-4521) to check for prior testing and treatment history. If there is no new exposure and no four-fold increase in titer, it may not be necessary to treat. All patients with syphilis should be tested for HIV if not already known to be HIV-infected. Nearly half of reported early syphilis cases among men who have sex with men in Monterey County were also HIV positive. o Sexually active gay, bisexual, and other men who have sex with men with syphilis who are HIV-negative should be evaluated for HIV pre-exposure prophylaxis (PrEP) and prescribed PrEP if appropriate. Contact the Monterey County’s HIV Programs for guidance on PrEP screening and prescribing (831-755-4626). Promptly report all suspected syphilis cases to the Health Department’s Communicable Disease Unit (phone: 831-755-4521; fax: 831-754-6682). STD Treatment Questions? There's an App for That The Centers for Disease Control and Prevention’s STD Treatment Guide app puts up-to-date treatment information at your fingertips. Download the 2015 STD Treatment (Tx) Guide app, an easy-to-use reference that combines information from the STD Treatment Guidelines as well as MMWR updates, and features a streamlined interface so providers can access treatment and diagnostic information. The free app is available for Apple devices and Android devices. Tuberculosis Interactive Core Curriculum on Tuberculosis: What the Clinician Should Know The Interactive Core Curriculum on Tuberculosis: What the Clinician Should Know provides clinicians and other public health professionals with information on diagnosing and treating latent TB infection and TB disease. The target audience of the course is clinicians caring for people with or at high risk for TB disease. This free, on-demand training, is available here. Continuing education (CE) is offered free of charge for various professions based on approximately 3.5 hours of instruction. To receive CE credit/contact hours, you must complete an exam and course evaluation. A minimum score of 70% is necessary to receive credit/contact hours. Upon successful completion of the course, exam, and evaluation, your CE certificate will be issued by CDC Training and Continuing Education Online. Chronic Disease Updates Prevention First Monterey County Project In this quarter, the Prevention First Monterey County (PFMC) team is working with Intrepid Ascent to plan for an Electronic Health Record (EHR) Learning Action Network (LAN) meeting with representatives from the major safety-net organizations to discuss EHR best-practices, population health, and next steps locally. As an update to the February Community Health Worker/Promotores LAN event, we would like to share that a CHW certificate program is in the planning phase at Cabrillo College in Santa Cruz County. An advisory committee has been developed to move this project forward with the intention to offer the CHW certificate program by 2019. Lastly, the PFMC team is finalizing their work on a Team Based Care Resource Report that will be made available through the PFMC website and posted in the July MCHD Provider Bulletin. Stay tuned! Learn more about the PFMC project and access additional resources here If you have any questions about the PFMC project, please contact Prevention First Project Coordinator, Kymber Senes. Diabetes Solera Health Launches MedicareDPP.org The site's goal is to increase awareness of and participation in diabetes prevention programs by making it easy for Medicare beneficiaries to learn their risk for type 2 diabetes, and if eligible, find and participate in a local diabetes prevention program that fits their needs and preferences. MedicareDPP.org will allow Medicare beneficiaries to: Verify health plan eligibility Confirm MDPP qualification (and capture blood test data) Access a diverse network of MDPP suppliers and enroll in the class that best meets their needs Clinician Overview: Solera Network Learn more American Medical Association-Prediabetes Screening and Referral in CMS Quality Payment Program Medicare offers new ways for health systems to potentially benefit financially from the work at the provider level for at-risk patients to prevent the onset of type 2 diabetes. Two AMA- suggested population-health Improvement Activities (IAs)—glycemic screening services and glycemic referring services—have been added to available options for physicians participating in the Medicare Quality Payment Program’s Merit-based Incentive Payment System (MIPS). L​ earn more Opioid Safety Addressing the Unique Challenges of Opioid Use Disorders in Women Women’s biological differences may influence susceptibility to substance abuse, which could have implications for prevention and treatment. In order to identify and treat women most at risk, health care providers must be able to recognize and consider these differences. Learn how to best address the complexities of opioid use disorder among women as speakers discuss ways to effectively care for and provide preventative services to female patients who struggle with the disease. Hot Training Topic: Women and Opioids Content from CDC Learning Connection Newsletter, May , 201 8 Opioid Safety: Interactive Training Series for Providers Earn FREE continuing education (CE) credit with this interactive, web-based training that features self-paced learning, case-based content, knowledge checks, and integrated resources to help healthcare providers gain a deeper understanding of the "Applying CDC's Guideline for Prescribing Opioids" interactive training series. Content from CDC COCA Learn Newsletter, April 30, 201 8 Assessing and Addressing Opioid Use Disorder-Applying CDC Guidelines for Prescribing Take CDC’s "Assessing and Addressing Opioid Use Disorder” course to learn about clinical tools that can help in risk assessment and clinical decision making, and earn free CE. Content from CDC COCA Learn Newsletter, April 30, 201 8 Heart Health Million Hearts: National Stroke Awareness Month 2018: Stroke Can Happen to Anyone at Any Time New data show that after decades
Recommended publications
  • Recognizing and Treating New and Emerging Infections Encountered in Everyday Practice

    Recognizing and Treating New and Emerging Infections Encountered in Everyday Practice

    Recognizing and treating new and emerging infections encountered in everyday practice STEVEN M. GORDON, MD NFECTIOUS DISEASES, pre- MiikWirj:« Although infectious diseases were once considered a dicted earlier in this cen- diminishing threat, new pathogens are constantly challenging tury to be eliminated as a the health care system. This article reviews the clinical presen- public health problem, re- tation, diagnosis, and treatment of seven emerging infections I main the chief cause of death that primary care physicians are likely to encounter. worldwide and a significant cause of death and morbidity in i Parvovirus B19 attacks erythrocyte precursors; the United States.1 Challenging infection is usually benign and self-limiting but can cause the US public health system are aplastic crises in patients with chronic hemolytic disorders. several newly identified patho- Hemorrhagic colitis due to Escherichia coli 0157:H7 infection gens (eg, human immunodefi- can lead to the hemolytic-uremic syndrome, especially in chil- ciency virus [HIV], Escherichia dren; it also can cause thrombotic thrombocytopenia purpura. coli 0157:H7, hepatitis C) and a Chlamydia pneumoniae causes a mild pneumonia that resem- resurgence of old diseases pre- bles mycoplasmal pneumonia. Bacillary angiomatosis primar- sumed to be under control (eg, ily affects immunocompromised patients, especially those tuberculosis, syphilis). Further, infected with human immunodeficiency virus (HIV). At least multiple-drug resistance in two organisms can cause bacillary angiomatosis: Bartonella hense- strains of pneumococci, gono- lae and Bartonella quintana. Hantavirus pulmonary syndrome cocci, enterococci, staphylo- is spread by exposure to the droppings of infected rodents. cocci, salmonella, and mycobac- Contrary to previous thought, HIV continues to replicate teria undermines efforts to throughout the course of the illness and does not have a latency control the diseases they cause.2 phase.
  • Lyme Disease Weather Also Means That Ticks Become More Active and This Can Agent by Feeding As Larvae on Certain Rodent Species

    Lyme Disease Weather Also Means That Ticks Become More Active and This Can Agent by Feeding As Larvae on Certain Rodent Species

    Spring and summer bring warm temperatures, just right for small and medium sized animals, but will also feed on people. walking in the woods and other outdoor activities. Warm These ticks typically become infected with the Lyme disease weather also means that ticks become more active and this can agent by feeding as larvae on certain rodent species. increase the risk of a tick-borne disease. The tick-borne dis- In the fall, the nymphs become adults and infected nymphs eases that occur most often in Virginia are Lyme disease, become infected adults. Adult blacklegged ticks prefer to feed Rocky Mountain spotted fever, and ehrlichiosis. on deer. However, adult ticks will occasionally bite people on warm days of the fall and winter and can transmit Lyme disease Lyme Disease at that time. Lyme disease is caused by infection with a bacterium called Borrelia burgdorferi. The number of Lyme disease cases Transmission of Lyme disease by the nymph or adult ticks reported in Virginia has increased substantially in recent years. does not occur until the tick has been attached and feeding on a human or animal host for at least 36 hours. The Tick The blacklegged tick (Ixodes scapularis), formerly known as The Symptoms the deer tick, is the only carrier of Lyme disease in the Eastern Between three days to several weeks after being bitten by an U.S. The blacklegged tick's name comes from it being the only infected tick, 70-90% of people develop a circular or oval rash, tick in the Eastern U.S. that bites humans and has legs that are called erythema migrans (or EM), at the site of the bite.
  • Reportable Disease Surveillance in Virginia, 2013

    Reportable Disease Surveillance in Virginia, 2013

    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
  • Lyme Disease Rocky Mountain Spotted Fever Tick Paralysis Haemobartonellosis Tularemia Ehrlichiosis Anaplasmosis

    Lyme Disease Rocky Mountain Spotted Fever Tick Paralysis Haemobartonellosis Tularemia Ehrlichiosis Anaplasmosis

    Fall is the beginning of tick season in our area. However, you can find ticks all year round if you like to hike or camp in the woods, or other type of outdoor activities. Ticks are not as easy to kill as fleas, but there are several different ways to control ticks from oral to topical medications and well as collars. If you find a tick embedded in your pet and you choose to try and remove it, be aware that you can accidentally leave the head behind. This can cause a local irritation even possibly an infection. We will be happy to assist with removing a tick for you to help prevent any problems. Protecting your cat or dog (or both) from ticks is an important part of disease prevention. In fact, there are several diseases that can be transmitted to your pet from a tick bite. Some of the most common tick-borne diseases seen in the Western United States are: Lyme Disease Rocky Mountain Spotted Fever Tick Paralysis Haemobartonellosis Tularemia Ehrlichiosis Anaplasmosis Lyme Disease Also called borreliosis, Lyme disease is caused by the bacteria Borrelia burgdorferi. Deer ticks carry these bacteria, transmitting them to the animal while sucking its blood. The tick must be attached to the dog (or cat) for about 48 hours in order to transmit the bacteria to the animal's bloodstream. If the tick is removed before this, transmission will usually not occur. Common signs of Lyme disease include lameness, fever, swollen lymph nodes and joints, and a reduced appetite. In severe cases, animals may develop kidney disease, heart conditions, or nervous system disorders.
  • Melioidosis in Northern Tanzania: an Important Cause of Febrile Illness?

    Melioidosis in Northern Tanzania: an Important Cause of Febrile Illness?

    Melioidosis and serological evidence of exposure to Burkholderia pseudomallei among patients with fever, northern Tanzania Michael Maze Department of Medicine University of Otago, Christchurch Melioidosis Melioidosis caused by Burkholderia pseudomallei • Challenging to identify when cultured Soil reservoir, with human infection from contact with contaminated water Most infected people are asymptomatic: 1 clinical illness for 4,500 antibody producing exposures Febrile illness with a variety of presentations and bacteraemia is present in 40-60% of people with acute illness Estimated 89,000 deaths globally Gavin Koh CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=4975784 Laboratory diagnosis of febrile inpatients, northern Tanzania, 2007-8 (n=870) Malaria (1.6%) Bacteremia (9.8%) Mycobacteremia (1.6%) Fungemia (2.9%) Brucellosis (3.5%) Leptospirosis (8.8%) Q fever (5.0%) No diagnosis (50.1%) Spotted fever group rickettsiosis (8.0%) Typhus group rickettsiosis (0.4%) Chikungunya (7.9%) Crump PLoS Neglect Trop Dis 2013; 7: e2324 Predicted environmental suitability for B. pseudomallei in East Africa Large areas of Africa are predicted to be highly suitable for Burkholderia pseudomallei East Africa is less suitable but pockets of higher suitability including northern Tanzania Northern Tanzania Increasing suitability for B. pseudomallei Limmathurotsakul Nat Microbiol. 2016;1(1). Melioidosis epidemiology in Africa Paucity of empiric data • Scattered case reports • Report from Kilifi, Kenya identified 4 bacteraemic cases from 66,000 patients who had blood cultured1 • 5.9% seroprevalence among healthy adults in Uganda2 • No reports from Tanzania 1. Limmathurotsakul Nat Microbiol. 2016;1(1). 2. Frazer J R Army Med Corps. 1982;128(3):123-30.
  • Rocky Mountain Spotted Fever

    Rocky Mountain Spotted Fever

    Department of Public Health Office of Epidemiology 4041 N Central Ave. Ste 600 Phoenix, AZ 85012 Rocky Mountain Spotted Fever Rocky Mountain Spotted Fever (RMSF) is a disease caused by the bacteria Rickettsia rickettsii. The bacteria are transmitted to humans through the bite of an infected tick, most commonly the American dog tick (Dermacentor variabilis) or Rocky Mountain wood tick (Dermacentor andersoni). The disease was first recognized in the Rocky Mountain area, however, despite the disease’s name, relatively few cases occur in the Rocky Mountain west. Most cases of RMSF occur in the Southeast and South central regions of the United States between the months of April and August, but in Arizona tick activity has been seen from March to September. RMSF used to be a rare disease in Arizona, however, it has become increasingly common over the last several years. Between 2003 and 2012, over 250 cases and 19 fatalities occurred in Arizona. Almost all of these cases occurred in areas with large amounts of free-roaming dogs and severe tick infestations, including six Tribal lands. During 2010-2011, RMSF in Arizona occurred at a rate ~200 times the national average. RMSF can be rapidly fatal if not treated within the first 5 days of symptom onset. Before tetracycline antibiotics were available, case fatality rates ranged from 20-80%. Signs and Symptoms Symptoms usually present in 2-14 days usually with a sudden onset of moderate to high fever, significant malaise, deep muscle pain, severe headache, chills and conjunctival infection. The “typical” triad of fever, rash, and tick bite are only presented between 21-40% of the time.
  • Rickettsia Felis, Bartonella Henselae, and B. Clarridgeiae, New Zealand

    Rickettsia Felis, Bartonella Henselae, and B. Clarridgeiae, New Zealand

    LETTERS Richard Reithinger,*† domestic and wild animals that also products obtained by PCR with Khoksar Aadil,† Samad Hami,† feeds readily on people. Recent stud- primers for the 17-kDa protein (4), and Jan Kolaczinski*† ies have implicated the cat flea as a citrate synthase (4), and PS 120 pro- *London School of Hygiene and Tropical vector of new and emerging infectious tein (5) genes. R. felis has been estab- Medicine, London, United Kingdom; and diseases (1). To determine the lished in tissue culture (XTC-2 and †HealthNet International, Peshawar, pathogens in C. felis in New Zealand, Vero cells) (6), and serologic testing Pakistan we collected 3 cat fleas from each of has been used to diagnose infections 11 dogs and 21 cats at the Massey (5). Reports indicate that patients References University Veterinary Teaching respond rapidly to doxycycline thera- 1. Ashford R, Kohestany K, Karimzad M. Hospital from May to June 2003. The py (5), and in vitro studies have Cutaneous leishmaniasis in Kabul: observa- fleas were stored in 95% alcohol until shown the organism is susceptible to tions on a prolonged epidemic. Ann Trop Med Parasitol 1992;86:361–71. they were identified by using morpho- rifampin, thiamphenicol, and fluoro- 2. Griffiths WDA. Old World cutaneous leish- logic criteria and washed in sterile quinolones. maniasis. In: Peters W, Killick-Kendrick R, phosphate-buffered saline. The DNA B. henselae is an agent of cat- editors. The leishmaniases in biology and from each flea was extracted individ- scratch disease, bacillary angiomato- medicine. London: Academic Press; 1987. p. 617–43. ually by using the QiaAmp Tissue Kit sis, bacillary peliosis, endocarditis, 3.
  • Rocky Mountain Spotted Fever in Children

    Rocky Mountain Spotted Fever in Children

    Rocky Mountain Spotted Fever in Children Charles R. Woods, MD, MS KEYWORDS Rocky mountain spotted fever Rickettsia rickettsii Rash Increased intracranial pressure Sepsis Doxycycline KEY POINTS Rocky Mountain spotted fever (RMSF) is typically undifferentiated from many other infec- tions in the first few days of illness. Treatment should not be delayed pending confirmation of infection when RMSF is suspected. Doxycycline is the drug of choice even for infants and children less than 8 years old. INTRODUCTION RMSF is caused by Rickettsia rickettsii, the prototypical member of the spotted fever subgroup of rickettsial species. RMSF was first recognized as a clinical entity in the 1890s in Idaho and Montana. In the past century, RMSF has been identified within 46 states in the United States. R rickettsii also causes disease in many parts of Central and South America, where the infection is given other names, such as Brazilian spotted fever or febre maculosa.1,2 The spotted fever subgroup of Rickettsia now consists of 20 known species that cause similar illnesses worldwide.3–5 R parkeri and other related species are present among tick populations in the United States. Infection by these related species may account in part for the apparent increase in probable, but not confirmed, cases of RMSF in the United States in recent years.6 RMSF remains a nationally notifiable disease, but reporting was changed in 2010 under the broader category of spotted fever rickettsiosis.7 The pathogenesis, clinical features, and management of infections caused by the various agents of spotted fever rickettsiosis are largely the same. Laboratory studies of R conorii, the cause of Mediterranean spotted fever, have provided many insights into R rickettsii infections.
  • COVID-19 Vaccine: How Did We Get Here So Quickly?

    COVID-19 Vaccine: How Did We Get Here So Quickly?

    DISEASE PREVENTION AND EPIDEMIOLOGY NEWSLETTER IN THIS ISSUE: COVID-19 Vaccine: How did we get here so quickly? .................................................1 Historical perspective on vaccine hesitancy ....................................................2 New mRNA vaccine technology ...............3 Laboratory Criteria of the Spotted Fever Rickettsiosis and Lyme Disease Case Definitions .................................................3 Parotitis Associated with Mumps and Other Viral Infections ................................5 Updates to the List of Reportable Conditions for 2021 ...................................6 EpiWINTER 2021Notes COVID-19 Vaccine: How did we get According to the New York Times, the longest periods in a typical vaccine development timeline belong to here so quickly? the Preclinical, Building factories, and Manufacturing Jane Kelly, MD phases, and none of the phases overlap (Thompson, Assistant State Epidemiologist 2020). Unlike this usual timeline and because of the Division of Acute Disease Epidemiology federal government’s commitment to purchasing vaccine, companies did not have to proceed sequentially to ensure How is it possible to develop and get a COVID-19 vaccine return on investment. In the COVID-19 vaccine timeline, to market in record time? Academic Research and Preclinical had a head start from Developing COVID-19 vaccine in record time was previous SARS work and the published genome; Phases possible because of some unprecedented events I, II, and III trials had some overlap; and Building factories related to an earlier disease from more than 15 years and Manufacturing phases began early on. ago – SARS. The SARS outbreak in 2003 prompted work on vaccine development that was abandoned when the disease was contained. The COVID-19 vaccine developers had that prior work upon which to build. By January 10, 2020, the SARS-CoV-2 (responsible for COVID-19) genome had been sequenced and released publicly.
  • Rocky Mountain Spotted Fever

    Rocky Mountain Spotted Fever

    Zoonosis Update Rocky Mountain spotted fever Ronald D. Warner, DVM, MPVM, PhD, DACVPM, and Wallace W. Marsh, MD, FAAP ocky Mountain spotted fever (RMSF), a classic SFG rickettsiae are transmitted by arthropods and cause Rmetazoonosis that involves both vertebrate and non- various illnesses worldwide, R rickettsii is the only one vertebrate reservoir hosts, is a seasonal disease of dogs known to be pathogenic for both animals and humans and humans in the Americas. The clinical illness was in the Western Hemisphere. first described among Native Americans, soldiers, and settlers in the Bitterroot River and Snake River valleys of Cycle of the Organism in Nature Montana and Idaho during the late 1890s, but remained and the Vectors unrecognized in dogs until the late 1970s. The causative Rickettsia rickettsii are maintained in nature by organism, Rickettsia rickettsii, was first described by transstadial passage within, and transovarial (vertical) Howard T. Ricketts in 1909 and is maintained in nature transmission between, generations of ixodid ticks. These by ixodid (hard-bodied) ticks via transmission to-and- ticks also vector R rickettsii to and from various rodent from various rodent reservoirs. As primary reservoir reservoirs and other small mammals. Naïve larval and hosts, the ticks vector R rickettsii to larger mammals; nymphal ticks become infected while feeding on small however, dogs and humans are the only ones that dis- rodents (eg, mice, voles, squirrels, or chipmunks) with play clinically recognizable illnesses. Rickettsia rickettsii acute rickettsemia.2,5 To enable transovarial transmission, are not naturally transmitted dog-to-dog, dog-to- female ticks need to ingest numerous rickettsiae or be human, or human-to-human.
  • Asymptomatic-Anaplasmosis Confirmation Using Genetic And

    Asymptomatic-Anaplasmosis Confirmation Using Genetic And

    Yoo et al. BMC Infectious Diseases (2020) 20:458 https://doi.org/10.1186/s12879-020-05170-9 CASE REPORT Open Access Asymptomatic-anaplasmosis confirmation using genetic and serological tests and possible coinfection with spotted fever group Rickettsia: a case report Jiyeon Yoo1†, Jong-Hoon Chung2†, Choon-Mee Kim3, Na Ra Yun2 and Dong-Min Kim2* Abstract Background: Anaplasmosis is an emerging acute febrile disease that is caused by a bite of an Anaplasma phagocytophilum–infected hard tick. As for healthy patients, reports on asymptomatic anaplasmosis resulting from such tick bites are rare. Case presentation: A 55-year-old female patient visited the hospital with a tick bite in the right infraclavicular region. The tick was suspected to have been on the patient for more than 10 days. PCR and an indirect immunofluorescence assay (IFA) were performed to identify tick-borne infectious diseases. The blood sample collected at admission yielded a positive result in nested PCR targeting Ehrlichia-orAnaplasma-specific genes groEL and ankA. Subsequent sequencing confirmed the presence of A. phagocytophilum, and seroconversion was confirmed by the IFA involving an A. phagocytophilum antigen slide. PCR detected no Rickettsia-specific genes [outer membrane protein A (ompA) or surface cell antigen 1 (sca1)], but seroconversion of spotted fever group (SFG) rickettsiosis was confirmed by an IFA. Conclusions: This study genetically and serologically confirmed an asymptomatic A. phagocytophilum infection. Although SFG rickettsiosis was not detected genetically, it was detected serologically. These findings indicate the possibility of an asymptomatic coinfection: anaplasmosis plus SFG rickettsiosis. It is, therefore, crucial for clinicians to be aware of potential asymptomatic anaplasmosis following a tick bite.
  • Health Alert Network Advisory: Tick-Borne Diseases in Nebraska

    Health Alert Network Advisory: Tick-Borne Diseases in Nebraska

    TO: Primary care providers, infectious disease, laboratories, infection control, and public health FROM Thomas J. Safranek, M.D. Jeff Hamik, MS State Epidemiologist Vector-borne Disease Epidemiologist 402-471-2937 PHONE 402-471-1374 PHONE 402-471-3601 FAX 402-471-3601 FAX RE: TICK-BORNE DISEASES IN NEBRASKA DATE: May 6, 2020 The arrival of spring marks the beginning of another tick season. In the interest of public health and prevention, our office seeks to inform Nebraska health care providers about the known tick- borne diseases in our state. Spotted fever rickettsia (SFR) including Rocky Mountain spotted fever (RMSF) SFR is a group of related bacteria that can cause spotted fevers including RMSF. Several of these SFR have similar signs and symptoms, including fever, headache, and rash, but are often less severe than RMSF. SFR are the most commonly reported tick-borne disease in Nebraska. Our office has reported a median of 26 cases (range 16-48) with SFR over the last 5 years (2015- 2019), an increase from 10 median cases (range 5-18) reported during 2010-2014. SFR, especially RMSF NEEDS TO BE A DIAGNOSTIC CONSIDERATION IN ANY PERSON WITH A FEVER AND A HISTORY OF EXPOSURE TO ENVIRONMENTS WHERE TICKS MIGHT BE PRESENT. The skin rash is not always present when the patient first presents to a physician. RMSF is frequently overlooked or misdiagnosed, with numerous reports of serious and sometimes fatal consequences. Nebraska experienced a fatal case of confirmed RMSF in 2015 where the diagnosis was missed and treatment was delayed until the disease was well advanced.